Mahesh Swaminathan

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Drug Administration

Tyrosine Kinase

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Therapeutic advances in hematology

JCO precision oncology

Expert review of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Mahesh Swaminathan, Jorge E Cortes
Update on the role of gemtuzumab-ozogamicin in the treatment of acute myeloid leukemia. Therapeutic advances in hematology 14 (2023)
Mahesh Swaminathan, Jorge E Cortes
Update on the role of gemtuzumab-ozogamicin in the treatment of acute myeloid leukemia. Therapeutic advances in hematology 14 (2023)
Mahesh Swaminathan, Mai M Aly, Abdul Moiz Khan, Bayan Al Share, Vikram Dhillon, Enxhi Lalo, Harry Ramos, Katherine G Akers, Seongho Kim, Suresh Kumar Balasubramanian
Efficacy analysis of different FLT3 inhibitors in patients with relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndrome. EJHaem 4 (1) (2022)
Mahesh Swaminathan, Mai M Aly, Abdul Moiz Khan, Bayan Al Share, Vikram Dhillon, Enxhi Lalo, Harry Ramos, Katherine G Akers, Seongho Kim, Suresh Kumar Balasubramanian
Efficacy analysis of different FLT3 inhibitors in patients with relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndrome. EJHaem 4 (1) (2022)
Abhay Singh, Nuria Mencia-Trinchant, Elizabeth A Griffiths, Alaa Altahan, Mahesh Swaminathan, Medhavi Gupta, Matthew Gravina, Rutaba Tajammal, Mark G Faber, LunBiao Yan, Eti Sinha, Duane C Hassane, David Neil Hayes, Monica L Guzman, Renuka Iyer, Eunice S Wang, Swapna Thota
Mutant PPM1D - and TP53 -Driven Hematopoiesis Populates the Hematopoietic Compartment in Response to Peptide Receptor Radionuclide Therapy. JCO precision oncology 6 (2022)
Mahesh Swaminathan, Eunice S Wang
Novel therapies for AML: a round-up for clinicians. Expert review of clinical pharmacology 13 (12) (2021)